Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

NCT03480022 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Pre Diabetes
Polycystic Ovary Syndrome
Obesity Android

Interventions

DRUG: Liraglutide Pen Injector [Saxenda]
DRUG: Placebo Liraglutide Pen Injector

Sponsor

Woman's

Collaborators

[object Object]